Middle East Pharmaceutical Industries Company (4016.SR) — Analyst estimates
Consensus analyst estimates for Middle East Pharmaceutical Industries Company — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 534M | 3.37 | 1 |
| 2027 | 626M | 4 | 1 |
| 2028 | 740M | 4.74 | 1 |
| 2029 | 861M | 6.06 | 1 |
Consensus analyst estimates by fiscal year.